{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:09:18Z","timestamp":1785290958610,"version":"3.55.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Pre-exposure prophylaxis (PrEP), a WHO-recommended HIV prevention method for people at high risk for acquiring HIV, is being increasingly implemented in many countries. Setting programmatic targets, particularly in generalised epidemics, could incorporate estimates of the size of the population likely to be eligible for PrEP using incidence-based thresholds. We estimated the proportion of men and women who would be eligible for PrEP and the number of HIV infections that could be averted in Malawi, Mozambique, and Zambia using prioritisation based on age, sex, geography, and markers of risk.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>We analysed the latest nationally representative Demographic and Health Surveys (DHS) of Malawi, Mozambique, and Zambia to determine the proportion of adults who report behavioural markers of risk for HIV infection. We used prevalence ratios (PRs) to quantify the association of these factors with HIV status. Using a multiplier method, we combined these proportions with the number of new HIV infections by district, derived from district-level modelled HIV estimates. Based on these numbers, different scenarios were analysed for the minimum number of person-years on PrEP needed to prevent 1 HIV infection (NNP).<\/jats:p>\n<jats:p>An estimated total of 38,000, 108,000, and 46,000 new infections occurred in Malawi, Mozambique, and Zambia in 2016, corresponding with incidence rates of 0.43, 0.63, and 0.57 per 100 person-years. In these countries, 9%\u201320% of new infections occurred among people with a sexually transmitted infection (STI) in the past 12 months and 40%\u201342% among people with either an STI or a non-regular sexual partner (NP) in the past 12 months (STINP). The models estimate that around 50% of new infections occurred in districts with incidence rates \u22651.0% in Mozambique and Zambia and \u22650.5% in Malawi. In Malawi, Mozambique, and Zambia, 35.1%, 21.9%, and 12.5% of the population live in these high-incidence districts. In the most parsimonious scenario, if women aged 15\u201334 years and men 20\u201334 years with an STI in the past 12 months living in high-incidence districts were to take PrEP, it would take a minimum of 65.8 person-years on PrEP to avert 1 HIV infection per year in Malawi, 35.2 in Mozambique, and 16.4 in Zambia. Our findings suggest that 3,300, 5,200, and 1,700 new infections could be averted per year in the 3 countries, respectively. Limitations of our study are that these values are based on modelled estimates of HIV incidence and self-reported behavioural risk factors from national surveys.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A large proportion of new HIV infections in these 3 African countries were estimated to occur among people who had either an STI or an NP in the past year, providing a straightforward means to set PrEP targets. Greater prioritisation of PrEP by district, sex, age, and behavioural risk factors resulted in lower NNPs thereby increasing PrEP cost-effectiveness, but also diminished the overall impact on reducing new infections<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1003482","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T23:09:23Z","timestamp":1610406563000},"page":"e1003482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-2818","authenticated-orcid":true,"given":"Dominik","family":"Stelzle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Godfrey-Faussett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obreniokibo","family":"Amiesimaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0988-9489","authenticated-orcid":true,"given":"Delivette","family":"Castor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Hodges-Mameletzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lastone","family":"Chitembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Baggaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"pmed.1003482.ref001","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2018"},{"key":"pmed.1003482.ref002","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2019"},{"key":"pmed.1003482.ref003","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2017"},{"key":"pmed.1003482.ref004","author":"World Health Organisation (WHO)","year":"2015","journal-title":"Guideline on when to start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV"},{"key":"pmed.1003482.ref005","author":"World Health Organization (WHO)","year":"2016","journal-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection"},{"issue":"9","key":"pmed.1003482.ref006","doi-asserted-by":"crossref","first-page":"PE402","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study","volume":"4","author":"J Molina","year":"2017","journal-title":"Lancet HIV"},{"issue":"5","key":"pmed.1003482.ref007","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"pmed.1003482.ref008","author":"World Health Organisation (WHO)","year":"2015","journal-title":"WHO Expands Recommendation on Oral Pre-exposure Prophylaxis of HIV Infection (PrEP)"},{"issue":"7","key":"pmed.1003482.ref009","doi-asserted-by":"crossref","first-page":"21104","DOI":"10.7448\/IAS.19.7.21104","article-title":"PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa","volume":"19","author":"JB McGillen","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"pmed.1003482.ref010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.7999","article-title":"HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel","volume":"312","author":"JM Marrazzo","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"pmed.1003482.ref011","doi-asserted-by":"crossref","first-page":"20227","DOI":"10.7448\/IAS.18.4.20227","article-title":"Rethinking HIV prevention to prepare for oral PrEP implementation for young African women","volume":"18","author":"CL Celum","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"pmed.1003482.ref012","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/sextrans-2015-052179","article-title":"Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control","volume":"92","author":"A Kamali","year":"2016","journal-title":"Sex Transm Infect"},{"key":"pmed.1003482.ref013","unstructured":"Joint United Nations Program on HIV\/AIDS (UNAIDS). Miles to go\u2014closing gaps, breaking barriers, righting injustices. UNAIDS: 2018."},{"issue":"12","key":"pmed.1003482.ref014","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV Preexposure Prophylaxis: A Review","volume":"319","author":"J Riddell","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"pmed.1003482.ref015","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"VA Fonner","year":"2016","journal-title":"AIDS"},{"key":"pmed.1003482.ref016","unstructured":"Bhatt S. New spatially-specific HIV estimates. International AIDS Conference; 2016; Durban, South Africa."},{"key":"pmed.1003482.ref017","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS Geospatial HIVE-Map Model. 2017."},{"key":"pmed.1003482.ref018","unstructured":"ICF. The DHS Program website. Funded by USAID. [cited 2019 Dec 11]. Available from: http:\/\/www.dhsprogram.com."},{"key":"pmed.1003482.ref019","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Prevention Gap Report. UNAIDS. 2016."},{"issue":"7760","key":"pmed.1003482.ref020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-019-1200-9","article-title":"Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017","volume":"570","author":"L Dwyer-Lindgren","year":"2019","journal-title":"Nature"},{"issue":"1","key":"pmed.1003482.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1743132813Y.0000000257","article-title":"Early predictors of remission in newly diagnosed epilepsy: a systematic approach to reviewing prognostic factor studies","volume":"36","author":"S Abimbola","year":"2014","journal-title":"Neurol Res"},{"key":"pmed.1003482.ref022","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Location, location\u2014Connecting people faster to HIV services. Geneva: 2013."},{"issue":"4","key":"pmed.1003482.ref023","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/QAI.0b013e318256b2f6","article-title":"Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States","volume":"60","author":"DK Smith","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"pmed.1003482.ref024","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/QAI.0b013e31827e622d","article-title":"An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention","volume":"62","author":"EM Kahle","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"pmed.1003482.ref025","first-page":"751","article-title":"A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis","volume":"64","author":"J Pintye","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pmed.1003482.ref026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/QAD.0b013e32835ca2dd","article-title":"The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis","volume":"27","author":"I Cremin","year":"2013","journal-title":"AIDS"},{"issue":"12","key":"pmed.1003482.ref027","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.annepidem.2018.09.006","article-title":"Trends in human immunodeficiency virus diagnoses among men who have sex with men in North America, Western Europe, and Australia, 2000\u20132014","volume":"28","author":"J Chapin-Bardales","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"35","key":"pmed.1003482.ref028","article-title":"HIV in the United Kingdom: Decline in New HIV Diagnoses in Gay and Bisexual Men in London, 2017 Report","volume":"201711","author":"Public Health England","journal-title":"Health Protection Report Advanced Access Report"},{"issue":"11","key":"pmed.1003482.ref029","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","article-title":"Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study","volume":"5","author":"AE Grulich","year":"2018","journal-title":"Lancet HIV"},{"issue":"2","key":"pmed.1003482.ref030","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2352-3018(19)30002-5","article-title":"Global PrEP roll-out: recommendations for programmatic success","volume":"6","author":"K Rivet Amico","year":"2019","journal-title":"Lancet HIV"},{"issue":"6","key":"pmed.1003482.ref031","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1016\/S2352-3018(19)30043-8","article-title":"Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV","volume":"6","author":"EPF Chow","year":"2019","journal-title":"Lancet HIV"},{"issue":"10195","key":"pmed.1003482.ref032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","article-title":"HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"394","author":"Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"pmed.1003482.ref033","doi-asserted-by":"crossref","first-page":"e1917134","DOI":"10.1001\/jamanetworkopen.2019.17134","article-title":"Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis","volume":"2","author":"JJ Ong","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"pmed.1003482.ref034","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1007\/s10461-020-02927-w","article-title":"Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil","volume":"24","author":"I Dourado","year":"2020","journal-title":"AIDS Behav"},{"key":"pmed.1003482.ref035","article-title":"Innovations in HIV care delivery during the COVID-19 pandemic: Policies to strengthen the Ending the Epidemic Initiative\u2013A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association","author":"WS Armstrong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pmed.1003482.ref036","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S2352-3018(20)30208-3","article-title":"Highlights of AIDS 2020","volume":"7","author":"P Harris","year":"2020","journal-title":"Lancet HIV"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T23:10:36Z","timestamp":1610406636000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003482"}},"subtitle":[],"editor":[{"given":"Kenneth K.","family":"Mugwanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003482","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]}}}